The Enfamil Lawsuit is part of a broader legal effort known as the Toxic Baby Formula NEC Lawsuit, which involves allegations against major infant formula manufacturers, including Mead Johnson, the maker of Enfamil.
The NEC Lawsuit involves claims that cow’s milk-based formulas, such as Enfamil, significantly increase the risk of Necrotizing Enterocolitis (NEC), a dangerous gastrointestinal condition that primarily affects premature infants and those with low birth weight.
NEC can lead to severe health complications, including intestinal perforation, sepsis, and even death.
Families of affected infants are seeking justice and compensation, arguing that the manufacturers failed to adequately warn about the risks associated with their products.
NEC Baby Formula Lawsuits are being pursued in both state courts and through multidistrict litigation (MDL) to streamline the handling of numerous similar cases.
The NEC Baby Formula MDL is centralized in the United States District Court for the Northern District of Illinois.
As these legal proceedings continue, families impacted by NEC are encouraged to consult with experienced attorneys to explore their legal options.
Our attorneys are currently accepting new cases for the Enfamil Lawsuit.
Contact us today for a free consultation or use the chatbot on this page to find out if you qualify to join other families filing Enfamil Lawsuits today.
Enfamil Baby Formula Products Named in the NEC Lawsuit
Baby formula brands mentioned in the NEC Lawsuits include Enfamil and Similac.
Specialized Enfamil baby formula given to preterm infants in the NICU or maternity ward of hospitals has been linked to an increased risk of NEC.
The specific types of Enfamil baby formulas mentioned in the NEC Lawsuits are not available to the general public.
Similac and Enfamil infant formulas named in these lawsuits are specifically administered by healthcare professionals and are not available for purchase at supermarkets and other stores.
The specific types of Enfamil baby formula products named in the NEC Lawsuits include:
- Enfamil Human Milk Fortifier Powder
- Human Milk Fortifier Liquid High Protein
- Human Milk Fortifier Liquid Standard Protein
- Human Milk Fortifier Acidified Liquid
- Enfamil NeuroPro Enfacare
- Enfamil Premature
- 20 Cal
- 24 Cal
- 24 Cal/fl oz HP
- 30 Cal
- Enfamil 24 and DHA & ARA Supplement
If your child developed NEC after being fed cow’s milk based (either Enfamil or Similac baby formula), you may be eligible to file an NEC baby formula lawsuit.
Contact our law firm today to find out if you’re eligible to join the NEC Baby Formula Litigation.
You can also use the chatbot on this page to find out if you qualify for the Enfamil Lawsuit instantly.
TorHoerman Law Obtains $495 Million Verdict Against Similac Manufacturer Abbott Laboratories in Premature Infant Formula Trial
In July 2024, TorHoerman Law secured a landmark $495 million verdict against Abbott Laboratories, the manufacturer of Similac baby formula.
This Similac Lawsuit was brought on behalf of a family whose premature infant developed necrotizing enterocolitis (NEC) after being fed Similac, leading to severe, life-altering injuries.
The jury awarded $95 million in compensatory damages and an additional $400 million in punitive damages, underscoring the severity of Abbott’s negligence.
This verdict highlights the legal responsibility of manufacturers to provide safe products and adequate warnings about potential risks.
TorHoerman Law’s victory is a significant step forward in holding corporations accountable for the harm caused by their products.
The case sets a powerful precedent for ongoing and future NEC Baby Formula Lawsuits.
What is the NEC Infant Formula MDL?
The NEC Infant Formula MDL (multidistrict litigation) is a federal proceeding that consolidates hundreds of individual lawsuits involving Enfamil and Similac infant formula containing cow’s milk that were fed to premature infants who later developed necrotizing enterocolitis (NEC).
In April 2022, the Judicial Panel on Multidistrict Litigation centralized these cases in the U.S. District Court for the Northern District of Illinois, where they are overseen by Judge Rebecca R. Pallmeyer.
The purpose of the MDL is to coordinate discovery, expert testimony, and pretrial rulings for cases that raise common factual questions, particularly whether fed cow’s milk formulas increased the risk of NEC in vulnerable infants and whether manufacturers adequately warned hospitals and parents.
An MDL is not the same as a class action.
In a class action, one lawsuit represents all affected individuals and typically results in a single, shared outcome.
In contrast, each family in the NEC MDL maintains its own individual case, with damages evaluated separately based on the child’s injuries, medical care, and long-term impact.
If cases do not resolve through settlement, they can be returned to their original courts for trial, preserving each family’s right to a jury.
Importantly, the MDL is only one track of the NEC litigation.
Many baby formula NEC lawsuits are also filed in state courts, where juries have already returned significant verdicts, such as the NEC baby formula trial handled by TorHoerman Law in Missouri state court.
These parallel proceedings allow families to pursue justice in multiple forums while the federal MDL addresses shared scientific and legal issues involving Enfamil formula products and similar hospital-administered formulas.
